Every 10-Q that Marchex, Inc. (MCHX) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow MCHX and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full MCHX filings page.
Marchex, Inc. reported revenue of $11.0 million for the quarter and $21.6 million for the six months ended June 30 2026, down from $11.7 million and $23.1 million a year earlier. The company posted a quarterly net loss applicable to common stockholders of $0.4 million and a six‑month net loss of $2.1 million, with basic and diluted loss per share of $0.01 for the quarter and $0.05 year‑to‑date.
Total operating expenses declined year‑over‑year, driven mainly by lower sales and marketing, product development, and general and administrative costs following reorganizations, partially offset by higher depreciation and costs tied to new customer pilots. Cash and cash equivalents were $8.2 million at June 30 2026, with total assets of $37.6 million and total liabilities of $8.6 million.
On July 1 2026, Marchex closed the acquisition of Archenia, Inc., issuing $10.0 million of 6% convertible promissory notes payable over 24 months, convertible into Class B shares at $1.80 per share. Additional contingent consideration of up to 4.0 million Class B shares may be issued based on Archenia’s post‑closing performance and integration targets.
Marchex, Inc. reported a smaller loss while revenue declined for the quarter ended March 31, 2026. Revenue was $10.6 million, down from $11.4 million a year earlier, and net loss narrowed to $1.7 million, or $0.04 per share for both Class A and B.
Cash and cash equivalents were $9.0 million, with total assets of $38.5 million and stockholders’ equity of $28.9 million. Operating cash outflow improved to $0.5 million from $2.6 million as working-capital swings moderated.
The company recorded a $0.2 million impairment tied to subleasing its Seattle headquarters and finalized a $2.1 million settlement related to the Telmetrics acquisition, payable through 2027. Marchex also signed a stock purchase agreement to acquire Archenia, Inc. for $10.0 million in 6% convertible notes plus up to 4.0 million Class B earnout shares, subject to approval by disinterested stockholders.
Marchex, Inc. reported softer results for Q3 2025 as revenue fell to $11.5 million from $12.6 million a year ago, reflecting lower call volumes, customer consolidations, migration effects, and macro headwinds. The quarter posted a net loss of $1.0 million (loss per share $0.02), compared with a $0.8 million loss in Q3 2024. Year to date, revenue was $34.6 million with a net loss of $2.9 million.
Operating expenses eased in product development but rose in general and administrative costs, including higher stock-based compensation, which totaled $0.9 million in Q3. Cash and equivalents were $10.3 million at September 30, 2025, down from $12.8 million at year-end; operating cash flow used was $1.5 million for the nine months. A domain asset sale generated a $0.6 million gain. Customer concentration remained notable: one customer represented 11% of Q3 revenue and 21% of receivables, with an independent dealer network at 15% of receivables. The 2025 share repurchase program (up to 3,000,000 Class B shares) had no buybacks. Subsequent to quarter-end, Marchex signed an agreement in principle to acquire Archenia via a $10 million 6% convertible note at $1.80 per share, subject to a definitive agreement and approval by disinterested stockholders, with closing anticipated in the first half of 2026.
Marchex reported revenue of $11.655 million for the quarter ended June 30, 2025, down 3% from $12.074 million a year earlier, and $23.058 million for the six months, down 2% year over year. The company recorded a small quarterly net income of $85 thousand (basic and diluted EPS $0.00) after narrowing its operating loss, but posted a six-month net loss of $1.897 million (basic/diluted loss per share approximately $0.04). Cash and cash equivalents were $10.491 million, total assets $41.984 million, and accumulated deficit $328.075 million.
Operational highlights: sales and marketing expense increased while product development declined due to capitalization and reorganization; cost of revenue remained ~35% of revenue. The company recognized a ~$0.6 million gain from a domain sale, authorized a new repurchase program to buy up to 3,000,000 Class B shares (no repurchases made), and recorded a 100% valuation allowance against deferred tax assets. One customer accounted for ~11% of revenue and 21% of receivables, and litigation over a prior acquisition earnout is in discovery.